29
/pt/
pt
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Criar
Public Timelines
Biblioteca
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Baixar
Export
Criar uma cópia
Incorporar ao site
Editar
Visualizações 309
0
0
New timeline
Apixaban clinical trial timeline
Criada
Sai Iyer Ph.D
⟶ Atualizado 4 out 2017 ⟶
List of edits
Comentários
Períodos
PHASE 3 OL - Apixaban vs. LMWH in clot reduction in CR-VTE
PHASE 1 - Single Dose of Apixaban in Pediatric Subjects at Risk for a Thrombotic Disorder
Phase 2 PK/safety vs. VKA and LMWH in pts w/ congenital or acquired heart disease
Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE
PH 3 - Clot reduction in leukemia pediatrics with central catheters
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
VTE prevention in multiple myeloma